BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8494732)

  • 21. Effect of angiotensin II and peptide YY on cerebral and circumventricular blood flow.
    Tuor UI; Kondysar MH; Harding RK
    Peptides; 1988; 9(1):141-9. PubMed ID: 3362742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of blood flow reduction to normal liver tissue induced by angiotensin, vasopressin and endothelin.
    Hennigan TW; Allen-Mersh TG
    Eur J Surg Oncol; 1994 Aug; 20(4):446-8. PubMed ID: 8076707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic hemodynamic responses to chronic angiotensin II infusion into the renal artery of dogs.
    Fitzgerald SM; Stevenson KM; Evans RG; Anderson WP
    Am J Physiol; 1997 Dec; 273(6):R1980-9. PubMed ID: 9435652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II.
    Burton MA; Gray BN; Self GW; Heggie JC; Townsend PS
    Cancer Res; 1985 Nov; 45(11 Pt 1):5390-3. PubMed ID: 4053012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U
    Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II.
    Hemingway DM; Angerson WJ; Anderson JH; Goldberg JA; McArdle CS; Cooke TG
    Br J Cancer; 1992 Nov; 66(5):958-60. PubMed ID: 1419643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.
    Trotter MJ; Olive PL; Chaplin DJ
    Br J Cancer; 1990 Dec; 62(6):903-8. PubMed ID: 2257217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension.
    Widgren BR; Herlitz H; Aurell M; Berglund G; Wikstrand J; Andersson OK
    Am J Hypertens; 1992 Mar; 5(3):167-74. PubMed ID: 1575943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    Hill JV; Findon G; Appelhoff RJ; Endre ZH
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of angiotensin II on intermittent tumour blood flow and acute hypoxia in the murine SCCVII carcinoma.
    Trotter MJ; Chaplin DJ; Olive PL
    Eur J Cancer; 1991; 27(7):887-93. PubMed ID: 1834122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats.
    Hof RP
    Br J Pharmacol; 1984 May; 82(1):51-60. PubMed ID: 6733358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension.
    Imig JD
    Am J Hypertens; 2000 Jul; 13(7):810-8. PubMed ID: 10933574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
    Brännström K; Morsing P; Arendshorst WJ
    Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgenic effects on angiotensin II-induced blood pressure and cochlear blood flow changes in rats.
    Flynn AJ; Dengerink HA; Wright JW
    Hear Res; 1990 Dec; 50(1-2):119-25. PubMed ID: 2076967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice.
    Honess DJ; Dennis IF; Bleehen NM
    Radiother Oncol; 1993 Sep; 28(3):208-18. PubMed ID: 8255998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
    Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases.
    Burke D; Davies MM; Zweit J; Flower MA; Ott RJ; Dworkin MJ; Glover C; McCready VR; Carnochan P; Allen-Mersh TG
    Br J Cancer; 2001 Nov; 85(11):1640-5. PubMed ID: 11742481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular reactivity to angiotensin II in the normotensive and hypertensive pregnant ewe.
    Lieb SM; Cabalum T; Zugaib M; Erkkola R; Tabsh K; Ushioda E; Nuwayhid BS; Brinkman CR; Assali NS
    Am J Physiol; 1980 Feb; 238(2):H209-13. PubMed ID: 7361915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow.
    Dworkin MJ; Carnochan P; Allen-Mersh TG
    Br J Cancer; 1997; 76(9):1205-10. PubMed ID: 9365170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effects of angiotensin II and other vasoactive agents on the blood flow in Yoshida ascites hepatoma].
    Li YL; Li HC; Zhang LH
    Zhonghua Yi Xue Za Zhi; 1993 Jan; 73(1):23-5, 61. PubMed ID: 8389231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.